Pengpeng Xu - Shanghai Institute of Hematology, Shanghai Jiao Tong University

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 130 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Targeted Agents Plus CHOP Compared with CHOP As the First-Line Treatment for Newly Diagnosed Patients with Peripheral T-Cell Lymphoma (GUIDANCE-03): an Open-Label, Multicentre Phase 2 Clinical Trial

Ming-Ci Cai,Shu Cheng,Hong-Mei Jing,Yan Liu,Guo-Hui Cui,Ting Niu,Jian-Zhen Shen,Liang Huang,Xin Wang,Yao-Hui Huang,Li Wang,Peng-Peng Xu,Wei-Li Zhao

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2024)

引用0浏览0WOS引用

CD47 Overexpression is Related to Tumour‐associated Macrophage Infiltration and Diffuse Large B‐cell Lymphoma Progression

Yi‐Ge Shen,Meng‐Meng Ji,Hong‐Mei Yi,Rong Shen,Di Fu,Shu Cheng,Chuan‐Xin Huang,Li Wang,Peng‐Peng Xu,Hong‐Jing Dou,Wei‐Li Zhao

Clinical and Translational Medicineno. 1 (2024)

引用0浏览0引用

The Genetic Landscape of Histologically Transformed Marginal Zone Lymphomas

Anqi Li,Hongmei Yi,Shijie Deng,Miao Ruan,Pengpeng Xu,Yujia Huo,Haiyang Lu,Xia Shen, Binsen Ouyang,Mingci Cai,Haimin Xu,Zhongyu Wang,Lei Zhang, Lingyan Zhu,Qi Peng,Yijin Gu,Jialing Xie,Yan Wang,Lei Dong,Zebing Liu,Chaofu Wang

CANCERno. 8 (2024): 1246-1256

引用0浏览0WOS引用

KMT2D Mutations Promoted Tumor Progression in Diffuse Large B-cell Lymphoma Through Altering Tumor-Induced Regulatory T Cell Trafficking Via FBXW7-NOTCH-MYC/TGF-81 Axis

Qing-Xiao Liu,Yue Zhu,Hong-Mei Yi, Yi-Ge Shen,Li Wang,Shu Cheng,Peng-Peng Xu,Hai-Min Xu,Lu-Ting Zhou, Yao-Hui Huang,Chuan-Xin Huang,Di Fu,Meng-Meng Ji,Chao-Fu Wang,Wei-Li Zhao

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCESno. 10 (2024): 3972-3985

引用0浏览0引用

18F-FDG PET/CT Metrics-Based Stratification of Large B-cell Lymphoma Receiving CAR-T Cell Therapy: Immunosuppressive Tumor Microenvironment As a Negative Prognostic Indicator in Patients with High Tumor Burden

Ling-Shuang Sheng,Rong Shen,Zi-Xun Yan, Chao Wang, Xin Zheng,Yi-Lun Zhang, Hao-Xu Yang,Wen Wu,Peng-Peng Xu,Shu Cheng,Emmanuel Bachy,Pierre Sesques,Nicolas Jacquet-Francillon,Xu-Feng Jiang,Wei-Li Zhao,Li Wang

Biomarker researchno. 1 (2024): 104-104

引用0浏览0WOS引用

Anti-metabolic Agent Pegaspargase Plus PD-1 Antibody Sintilimab for First-Line Treatment in Advanced Natural Killer T Cell Lymphoma

Jie Xiong,Shu Cheng, Xiao Gao,Shan-He Yu,Yu-Ting Dai,Xin-Yun Huang,Hui-Juan Zhong,Chao-Fu Wang,Hong-Mei Yi, Hao Zhang,Wei-Guo Cao,Rong Li,Wei Tang,Yan Zhao,Peng-Peng Xu,Li Wang,Wei-Li Zhao

SIGNAL TRANSDUCTION AND TARGETED THERAPYno. 1 (2024)

引用0浏览0WOSNATURE引用

肾脏累及的弥漫性大B细胞淋巴瘤患者临床病理特征

王博恩, 陈思远,施晴,张慕晨,易红梅,董磊,王黎,程澍,许彭鹏,赵维莅

Journal of Shanghai Jiaotong University(Medical Science)no. 9 (2024)

引用0浏览0引用

Tucidinostat Plus R-CHOP in Previously Untreated Diffuse Large B-cell Lymphoma with Double Expression of MYC and BCL2: an Interim Analysis from the Phase III DEB Study

Weili Zhao,Jun Zhu,Yuqin Song,Peng-Peng Xu,Jianzhen Shen,Qingqing Cai,Hui Zhou, Liling Zhang,Ying Xiang,Xiuhua Sun,Wei Yang,Zhihua Yao,Hongmei Jing, Shujuan Wen,Jie Jin,Hongwei Xue,Hong Cen,Kaiyang Ding,Zhengming Jin,Xiaojing Xing

JOURNAL OF CLINICAL ONCOLOGYno. 17_SUPPL (2024): LBA7003-LBA7003

引用0浏览0引用

Biological Signatures of the International Prognostic Index in Diffuse Large B-cell Lymphoma

Yue Wang,Qing Shi,Zi-Yang Shi,Shuang Tian,Mu-Chen Zhang,Rong Shen,Di Fu,Lei Dong,Hong-Mei Yi,Bin-Shen Ouyang,Rong-Ji Mu,Shu Cheng,Li Wang,Peng-Peng Xu,Wei -Li Zhao

BLOOD ADVANCESno. 7 (2024): 1587-1599

引用0浏览0WOS引用

Cholesterol Efflux from C1QB-expressing Macrophages is Associated with Resistance to Chimeric Antigen Receptor T Cell Therapy in Primary Refractory Diffuse Large B Cell Lymphoma

Zi-Xun Yan, Yan Dong,Niu Qiao,Yi-Lun Zhang,Wen Wu,Yue Zhu,Li Wang,Shu Cheng,Peng-Peng Xu,Zi-Song Zhou,Ling-Shuang Sheng,Wei-Li Zhao

NATURE COMMUNICATIONSno. 1 (2024)

引用0浏览0WOSNATURE引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn